FGFR2 and neoplasm: Taken together, although the study is limited to a relatively small cohort, the findings suggest that FGFR2 expression may be associated with features of an immunosuppressive TIME in luminal BCa, and could serve as a potential biomarker for identifying this tumour microenvironment subtype.